COVID-19 treatment | Natco Pharma seeks approval to launch phase-3 trial of Molnupiravir

COVID-19 treatment | Natco Pharma seeks approval to launch phase-3 trial of Molnupiravir Natco said it is hoping that CDSCO would give emergency approval of this drug based on “compassionate use” for patients.

No comments:

Post a Comment